Cargando…

Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling

Lung cancer is the most deadly neoplasm with the highest incidence in both genders, with non-small cell lung cancer (NSCLC) being the most frequent subtype. Somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene are key drivers of NSCLC progression, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raquel-Cunha, Ana, Cardoso-Carneiro, Diana, Reis, Rui M., Martinho, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562953/ https://www.ncbi.nlm.nih.gov/pubmed/31083461 http://dx.doi.org/10.3390/cells8050442

Ejemplares similares

RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer
por: Gabriela-Freitas, Maria, et al.
Publicado: (2019)

The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart
por: Abd Alla, Joshua, et al.
Publicado: (2022)

Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival
por: Huerta-Yepez, Sara, et al.
Publicado: (2011)

Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression
por: Cheng, Xiao-Ke, et al.
Publicado: (2016)

Investigation of Marine-Derived Natural Products as Raf Kinase Inhibitory Protein (RKIP)-Binding Ligands
por: Parate, Shraddha, et al.
Publicado: (2021)

Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer
por: Yousuf, Saad, et al.
Publicado: (2014)

Retraction: Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer
Publicado: (2021)

Cefotetan-bound human RKIP involves in Ras/Raf1/MEK/ERK signaling pathway: Structural basis of the cefotetan-hRKIP interaction
por: Guo, Chenyun, et al.
Publicado: (2022)

Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
por: Martinho, Olga, et al.
Publicado: (2012)

Characterization of the Raf Kinase Inhibitory Protein (RKIP) Binding Pocket: NMR-Based Screening Identifies Small-Molecule Ligands
por: Shemon, Anne N., et al.
Publicado: (2010)

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
por: Karamitopoulou, Eva, et al.
Publicado: (2013)

A Model of Induction of Cerebellar Long-Term Depression Including RKIP Inactivation of Raf and MEK
por: Hepburn, Iain, et al.
Publicado: (2017)

Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
por: Carrot-Zhang, Jian, et al.
Publicado: (2021)

Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
por: Carrot-Zhang, Jian, et al.
Publicado: (2021)

RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
por: Wong, Samantha, et al.
Publicado: (2023)

RKIP Inhibition in Cervical Cancer Is Associated with Higher Tumor Aggressive Behavior and Resistance to Cisplatin Therapy
por: Martinho, Olga, et al.
Publicado: (2013)

FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections
por: Meineke, Robert, et al.
Publicado: (2022)

Ligand Binding Study of Human PEBP1/RKIP: Interaction with Nucleotides and Raf-1 Peptides Evidenced by NMR and Mass Spectrometry
por: Tavel, Laurette, et al.
Publicado: (2012)

RTK Inhibitors in Melanoma: From Bench to Bedside
por: Sabbah, Malak, et al.
Publicado: (2021)

RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis
por: Zebisch, Armin, et al.
Publicado: (2019)

Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors
por: Marusiak, Anna A., et al.
Publicado: (2014)

Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis
por: Campanella, Nathália Cristina, et al.
Publicado: (2023)

Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib
por: Tkacik, Emre, et al.
Publicado: (2023)

Dioscorea nipponica Makino Relieves Ovalbumin-Induced Asthma in Mice through Regulating RKIP-Mediated Raf-1/MEK/MAPK/ERK Signaling Pathway
por: Wang, Weiyi, et al.
Publicado: (2022)

Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma
por: Papale, Massimo, et al.
Publicado: (2017)

Targeting the Raf kinases in human cancer: the Raf dimer dilemma
por: Durrant, David E, et al.
Publicado: (2018)

Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
por: Holderfield, M, et al.
Publicado: (2014)

RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017)

Raf Kinase Inhibitor Protein (RKIP) Inhibits Tumor Necrosis Factor-α (TNF-α) Induced Adhesion Molecules Expression in Vascular Smooth Muscle Bells by Suppressing (Nuclear Transcription Factor-κB (NF-kappaB) Pathway
por: Jing, Shen-Hong, et al.
Publicado: (2017)

Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015)

Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
por: Ledda, Fernanda, et al.
Publicado: (2007)

The biological complexity of RKIP signaling in human cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015)

TROY interacts with RKIP to promote glioma development
por: Liu, Xiujie, et al.
Publicado: (2018)

Harnessing RKIP to Combat Heart Disease and Cancer
por: Lorenz, Kristina, et al.
Publicado: (2022)

Insights of RKIP-Derived Suppression of Prostate Cancer
por: Dong, Ying, et al.
Publicado: (2021)

The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment
por: Cessna, Hannah, et al.
Publicado: (2022)

Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
por: Chatelle, Claire V., et al.
Publicado: (2016)

Targeting RTK Signaling Pathways in Cancer
por: Regad, Tarik
Publicado: (2015)

The trigger (and the restriction) of Torso RTK activation
por: Mineo, Alessandro, et al.
Publicado: (2018)

On the Problem of Double-Filtering in PPP-RTK
por: Khodabandeh, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b7ka00d91furfv7v26ecp0k38s